152 related articles for article (PubMed ID: 25082275)
1. Harnessing the informatics revolution for neuroscience drug R&D.
Manji HK; Insel TR; Narayan VA
Nat Rev Drug Discov; 2014 Aug; 13(8):561-2. PubMed ID: 25082275
[No Abstract] [Full Text] [Related]
2. ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin.
Nutt D; Goodwin G
Eur Neuropsychopharmacol; 2011 Jul; 21(7):495-9. PubMed ID: 21684455
[No Abstract] [Full Text] [Related]
3. Removing obstacles in neuroscience drug discovery: the future path for animal models.
Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
[TBL] [Abstract][Full Text] [Related]
4. The Human Brain Project-Synergy between neuroscience, computing, informatics, and brain-inspired technologies.
Amunts K; Knoll AC; Lippert T; Pennartz CMA; Ryvlin P; Destexhe A; Jirsa VK; D'Angelo E; Bjaalie JG
PLoS Biol; 2019 Jul; 17(7):e3000344. PubMed ID: 31260438
[TBL] [Abstract][Full Text] [Related]
5. Where will new neuroscience therapies come from?
Schoepp DD
Nat Rev Drug Discov; 2011 Sep; 10(10):715-6. PubMed ID: 21959271
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and information technology: reshaping the drug discovery process.
Augen J
Drug Discov Today; 2002 Jun; 7(11):S39-40. PubMed ID: 12047878
[No Abstract] [Full Text] [Related]
7. Changing requirements and resulting needs for IT-infrastructure for longitudinal research in the neurosciences.
Buckow K; Quade M; Rienhoff O; Nussbeck SY
Neurosci Res; 2016 Jan; 102():22-8. PubMed ID: 25152316
[TBL] [Abstract][Full Text] [Related]
8. Optogenetics enlightens neuroscience drug discovery.
Song C; Knöpfel T
Nat Rev Drug Discov; 2016 Feb; 15(2):97-109. PubMed ID: 26612666
[TBL] [Abstract][Full Text] [Related]
9. Translational Informatics Connects Real-World Information to Knowledge in an Increasingly Data-Driven World.
McDonough CW; Breitenstein MK; Shahin M; Empey PE; Freimuth RR; Li L; Liebman M; Tuteja S
Clin Pharmacol Ther; 2020 Apr; 107(4):738-741. PubMed ID: 31837229
[No Abstract] [Full Text] [Related]
10. Optogenetic Approaches to Drug Discovery in Neuroscience and Beyond.
Zhang H; Cohen AE
Trends Biotechnol; 2017 Jul; 35(7):625-639. PubMed ID: 28552428
[TBL] [Abstract][Full Text] [Related]
11. The Olfactory Neural Epithelium As a Tool in Neuroscience.
Lavoie J; Gassó Astorga P; Segal-Gavish H; Wu YC; Chung Y; Cascella NG; Sawa A; Ishizuka K
Trends Mol Med; 2017 Feb; 23(2):100-103. PubMed ID: 28108112
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology in neuroscience drug discovery: quo vadis?
Trist DG; Cohen A; Bye A
Curr Opin Pharmacol; 2014 Feb; 14():50-3. PubMed ID: 24565012
[TBL] [Abstract][Full Text] [Related]
13. Neuroscience networking: linking discovery to drugs.
Heemskerk J; Farkas R; Kaufmann P
Neuropsychopharmacology; 2012 Jan; 37(1):287-9. PubMed ID: 22157858
[TBL] [Abstract][Full Text] [Related]
14. Informatics for neglected diseases collaborations.
Bost F; Jacobs RT; Kowalczyk P
Curr Opin Drug Discov Devel; 2010 May; 13(3):286-96. PubMed ID: 20443162
[TBL] [Abstract][Full Text] [Related]
15. Reductionism and proxy failure: From neuroscience to target-based drug discovery.
Sadri A; Paknezhad S
Behav Brain Sci; 2024 May; 47():e83. PubMed ID: 38738353
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward.
Cywin CL; Tamiz AP
Neurotherapeutics; 2017 Oct; 14(4):1066-1069. PubMed ID: 28405931
[No Abstract] [Full Text] [Related]
17. Neuroscience in the era of functional genomics and systems biology.
Geschwind DH; Konopka G
Nature; 2009 Oct; 461(7266):908-15. PubMed ID: 19829370
[TBL] [Abstract][Full Text] [Related]
18. CNS drug development - lost in translation?
Talevi A; Bellera CL; Di Ianni M; Gantner M; Bruno-Blanch LE; Castro EA
Mini Rev Med Chem; 2012 Sep; 12(10):959-70. PubMed ID: 22420574
[TBL] [Abstract][Full Text] [Related]
19. Receptor variants and the development of centrally acting medications
.
Neale SA; Kambara K; Salt TE; Bertrand D
Dialogues Clin Neurosci; 2019; 21(2):149-157. PubMed ID: 31636489
[TBL] [Abstract][Full Text] [Related]
20. Implications of sex-related differences in central nervous system disorders for drug research and development.
Butlen-Ducuing F; Balkowiec-Iskra E; Dalla C; Slattery DA; Ferretti MT; Kokras N; Balabanov P; De Vries C; Mellino S; Santuccione Chadha A
Nat Rev Drug Discov; 2021 Dec; 20(12):881-882. PubMed ID: 34226696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
